|
Name |
(1R,2R,5S,8S,9S,10R,11S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
|
| Molecular Formula | C19H23O5- | |
| IUPAC Name* |
(1R,2R,5S,8S,9S,10R,11S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
|
|
| SMILES |
C[C@]12CCC[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)[O-])OC2=O
|
|
| InChI |
InChI=1S/C19H24O5/c1-10-8-17-9-18(10,23)7-4-11(17)19-6-3-5-16(2,15(22)24-19)13(19)12(17)14(20)21/h11-13,23H,1,3-9H2,2H3,(H,20,21)/p-1/t11-,12-,13-,16+,17+,18+,19-/m1/s1
|
|
| InChIKey |
OXFPYCSNYOFUCH-AODVQFRNSA-M
|
|
| Synonyms |
GA20
|
|
| CAS | NA | |
| PubChem CID | 25201798 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 331.4 | ALogp: | 1.9 |
| HBD: | 1 | HBA: | 5 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 86.7 | Aromatic Rings: | 5 |
| Heavy Atoms: | 24 | QED Weighted: | 0.579 |
| Caco-2 Permeability: | -5.897 | MDCK Permeability: | 0.00000678 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.082 |
| Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.909 |
| 30% Bioavailability (F30%): | 0.442 |
| Blood-Brain-Barrier Penetration (BBB): | 0.377 | Plasma Protein Binding (PPB): | 42.30% |
| Volume Distribution (VD): | 0.353 | Fu: | 50.18% |
| CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.95 |
| CYP2C19-inhibitor: | 0.013 | CYP2C19-substrate: | 0.555 |
| CYP2C9-inhibitor: | 0.015 | CYP2C9-substrate: | 0.095 |
| CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.111 |
| CYP3A4-inhibitor: | 0.364 | CYP3A4-substrate: | 0.049 |
| Clearance (CL): | 5.65 | Half-life (T1/2): | 0.236 |
| hERG Blockers: | 0.043 | Human Hepatotoxicity (H-HT): | 0.84 |
| Drug-inuced Liver Injury (DILI): | 0.047 | AMES Toxicity: | 0.01 |
| Rat Oral Acute Toxicity: | 0.386 | Maximum Recommended Daily Dose: | 0.777 |
| Skin Sensitization: | 0.035 | Carcinogencity: | 0.512 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.014 |
| Respiratory Toxicity: | 0.955 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002542 | ![]() |
0.718 | D0I2SD | ![]() |
0.276 | ||
| ENC002555 | ![]() |
0.667 | D0IX6I | ![]() |
0.269 | ||
| ENC001071 | ![]() |
0.529 | D04GJN | ![]() |
0.264 | ||
| ENC000143 | ![]() |
0.489 | D0Z1XD | ![]() |
0.257 | ||
| ENC002558 | ![]() |
0.426 | D0KR5B | ![]() |
0.257 | ||
| ENC000794 | ![]() |
0.404 | D0R7JT | ![]() |
0.252 | ||
| ENC002556 | ![]() |
0.394 | D0X4RS | ![]() |
0.250 | ||
| ENC002559 | ![]() |
0.381 | D0EP0C | ![]() |
0.246 | ||
| ENC002554 | ![]() |
0.375 | D0Q4SD | ![]() |
0.240 | ||
| ENC002007 | ![]() |
0.358 | D07BSQ | ![]() |
0.238 | ||